Glatiramer Acetate Injection, Solution
Product Images NDC 47335-990

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 47335-990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Glatirtamer Actetate Injection (Glatiramer Acetate 20 mg Per mL 1)

FDA Label Image

Figure G (Glatiramer Acetate 20 mg Per mL 10)

FDA Label Image

Figure H (Glatiramer Acetate 20 mg Per mL 11)

FDA Label Image

Figure I (Glatiramer Acetate 20 mg Per mL 12)

FDA Label Image

Figure J (Glatiramer Acetate 20 mg Per mL 13)

FDA Label Image

Figure K (Glatiramer Acetate 20 mg Per mL 14)

FDA Label Image

Figure L (Glatiramer Acetate 20 mg Per mL 15)

FDA Label Image

Logo Sun Pharma (Glatiramer Acetate 20 mg Per mL 16)

FDA Label Image

Glatiramer Acetate Injection 20 mg/ml (Box)

Glatiramer Acetate Injection 20 mg/ml (Box)
This is a prescription medication with NDC 47335-990-02, containing 30 single-dose pre-filled syringes of Glatiramer Acetate injection at a concentration of 20 mg/mL for once-daily subcutaneous administration. This medication is available through prescription only and is manufactured by SUN PHARMA.*
FDA Label Image

Figure 2 Glatiramer Acetate Injection (Glatiramer Acetate 20 mg Per mL 2)

FDA Label Image

Logo Sun Pharma (Glatiramer Acetate 20 mg Per mL 3)

FDA Label Image

Figure A (Glatiramer Acetate 20 mg Per mL 4)

FDA Label Image

Figure B (Glatiramer Acetate 20 mg Per mL 5)

FDA Label Image

Figure C (Glatiramer Acetate 20 mg Per mL 6)

Figure C (Glatiramer Acetate 20 mg Per mL 6)
This text provides guidelines on where to avoid applying a product on various body parts such as the abdomen, back of hips, arms, and thighs. For the abdomen, it suggests avoiding about 2 inches around the belly button. In the back of hips and arms, it advises avoiding fleshy areas of the upper hips and the upper back portion of the arms. Additionally, for the thighs, it recommends avoiding about 2 inches above the knee and 2 inches below the groin. These instructions can help ensure precise application.*
FDA Label Image

Figure D (Glatiramer Acetate 20 mg Per mL 7)

FDA Label Image

Figure E (Glatiramer Acetate 20 mg Per mL 8)

FDA Label Image

Figure F (Glatiramer Acetate 20 mg Per mL 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.